Ocular Rosacea Management

Initial Assessment and Recognition

Ocular rosacea affects approximately 75% of patients with cutaneous rosacea and can present before skin manifestations, particularly in children, with key ocular features including blepharitis, meibomian gland dysfunction, chronic conjunctival injection, and foreign body sensation 1
The American Academy of Ophthalmology recommends identifying ocular features such as blepharitis with eyelid margin telangiectasias, meibomian gland dysfunction with inspissation and excessive sebum secretion, and chronic conjunctival injection and hyperemia in patients with ocular rosacea 1
Evaporative dry eye is a common feature of ocular rosacea, and the American Academy of Ophthalmology recommends its identification and management 2, 1
Chalazia are often recurrent in patients with ocular rosacea, and the American Academy of Ophthalmology recommends their management by an ophthalmologist 2, 1

The British Association of Dermatologists recommends initiating eyelid hygiene and artificial tears immediately for patients with mild ocular rosacea, and referring to ophthalmology for any symptoms beyond mild burning/stinging that don't respond to these basic measures within 2-4 weeks 3
The American Academy of Ophthalmology recommends oral doxycycline as first-line pharmacological treatment for moderate ocular rosacea, with a treatment duration of 6-12 weeks minimum before declaring failure 3
The American Academy of Ophthalmology recommends avoiding long-term corticosteroid therapy due to risk of glaucoma and cataracts, and using brief courses of topical corticosteroids for severe eyelid or ocular surface inflammation 2

The British Association of Dermatologists recommends using combination treatments, including lid hygiene, artificial tears, and oral doxycycline, for patients with multiple ocular features, with a 90% response rate achieved in the 2024 systematic review 3, 4

The British Association of Dermatologists recommends using the minimum treatment necessary to maintain control, with maintenance approach depending on initial treatment modality used, patient preference, and severity of initial presentation 4, 3

The American Academy of Pediatrics recommends that tetracyclines, including doxycycline, are contraindicated in pregnancy, nursing women, children under 8 years, and patients with hypersensitivity, and alternative agents must be selected by ophthalmology for pediatric cases requiring systemic therapy 2

The British Association of Dermatologists recommends referring patients to ophthalmology for any ocular symptoms beyond mild burning/stinging, symptoms not controlled with lid hygiene alone, blurred vision, photophobia, or foreign body sensation, recurrent chalazia or hordeola, any corneal involvement, and pediatric patients with ocular symptoms 3, 2, 1

The British Journal of Dermatology recommends initial treatment for ocular rosacea should be eyelid hygiene combined with artificial tear substitutes for mild symptoms, with oral doxycycline as the first-line pharmacological treatment for cases that don't respond to basic measures 5, 6, 7
Ocular rosacea is a chronic inflammatory condition that often accompanies cutaneous rosacea but can also occur independently, with common manifestations including blepharitis, blurred vision, foreign body sensation, interpalpebral bulbar hyperaemia, photophobia, redness and tearing, and telangiectasia of eyelid margins 6, 7, 8

The American Academy of Ophthalmology suggests eyelid hygiene as the first-line approach for all patients with ocular rosacea 6
Artificial tear substitutes are recommended for mild ocular burning/stinging, according to the American Academy of Ophthalmology 7, 9
General eye care is an underlying approach to managing ocular features, as recommended by the British Journal of Dermatology 5, 10
Trigger avoidance is considered important, though limited RCT evidence exists, as noted by the British Journal of Dermatology 5, 10

Oral doxycycline is the first-line pharmacological treatment for ocular rosacea that doesn't respond to basic measures, available in standard formulations (≥50 mg with antibiotic activity) and as 40-mg modified-release (MR) dose with anti-inflammatory but not antibiotic activity in some regions, as recommended by the British Journal of Dermatology 5, 11
Topical cyclosporine 0.05% may be helpful in some patients with posterior blepharitis, according to the American Academy of Ophthalmology 6, 9
Brief course of topical corticosteroids is recommended for severe eyelid or ocular surface inflammation, which should be tapered once inflammation is controlled and long-term corticosteroid therapy should be avoided, as suggested by the American Academy of Ophthalmology 6, 9, 12

Treatment duration should allow sufficient time (6-12 weeks) before considering a treatment failure, as recommended by the British Journal of Dermatology 5, 10
Referral to an ophthalmologist is necessary for ocular rosacea that cannot be controlled with lid hygiene or for greater severity, according to the British Journal of Dermatology 7, 8
Contraindications for tetracyclines include pregnancy, nursing women, children under 8 years, or those with hypersensitivity, as noted by the American Academy of Ophthalmology 9, 12
Combination therapy may be required for moderate to severe presentations, and maintenance therapy should use the minimum treatment necessary to maintain control, as recommended by the British Journal of Dermatology 5, 7, 11, 13